Iceland· IS-EU/1/25/2003/001-006
Inluriyo
A anti-estrogens product containing imlunestrant tosilate, registered in Iceland by Eli Lilly Nederland B.V.*. The same ATC class is registered in 5 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Imlunestrant tosilate is registered in 5 of 19 countries.
Countries holding a registration under ATC L02BA (anti-estrogens), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 3 of them publish a price we can compare per daily dose
Imlunestrant tosilate · ATC L02BA
5 / 19 countries
- Czechiaprice
- Denmark
- Icelandprice
- Ireland
- Switzerlandprice
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Imlunestrant tosilate
- Manufacturer
- Eli Lilly Nederland B.V.*
- Country
- Iceland (IS)
- ATC code
- L02BA
- ATC class
- Anti-estrogens
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Imlunestrant tosilate in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaINLURIYOEli Lilly Nederland B.V., Utrecht
- SwitzerlandInluriyo 200 mg, comprimés pelliculésEli Lilly (Suisse) SA
- United StatesInluriyoEli Lilly and Company
- BelgiumInluriyo 200 mgEli Lilly Nederland
- NetherlandsInluriyo 200 mg filmomhulde tablettenEli Lilly Nederland B.V.
- PolandInluriyoEli Lilly Nederland B.V.
- SwedenInluriyo 200 mg Filmdragerad tablettEli Lilly Nederland B.V.
- IrelandInluriyo 200 mg film-coated tabletsEli Lilly and Company Limited
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Liechtenstein · Inluriyo
- Norway · Inluriyo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/458179ad-66bd-4d23-9e63-229b561d2daf GET /v1/drugs/458179ad-66bd-4d23-9e63-229b561d2daf?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Filmuhúðuð tafla",
"source": "lyfjastofnun",
"atc_raw": "L02BA",
"marketed": false,
"strength": "200 mg",
"ma_number": "EU/1/25/2003/001-006",
"substance": "Imlunestrant tosilate",
"other_info": "Ávísun lyfsins er bundin við sérfræðinga í krabbameinslækningum.",
"legal_status": "(R Z) Sérfræðingsmerkt (og lyfseðilsskylt)",
"ma_issued_serial": "46031"
}See everything about imlunestrant tosilate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.